CONTACT YOUR POLICYMAKERS
Email your governor and state Medicaid director today urging them to commit to lifting these barriers for Medicaid beneficiaries to eliminate hepatitis C.
The Time for Viral Hepatitis Elimination is Now
25
State Medicaid programs have removed prior authorization on HCV treatment, one of the most stubborn barriers blocking access to care for millions of Americans.
And the countdown is on...
until the WHOs 2030 target for global viral hepatitis elimination.
SEE HOW YOUR STATE MATCHES UP
As of August 2023, the following 25 states have removed prior authorization for most patients: Alaska, Arizona, California, Colorado, Delaware, District of Columbia, Florida, Hawaii, Idaho, Illinois, Indiana, Louisiana, Massachusetts, Michigan, Missouri, New Hampshire, New York, Oklahoma, Oregon, Pennsylvania, Rhode Island, Texas, Virginia, Washington, Wisconsin.
The above grades reflect our most up-to-date assessment of Medicaid recipients’ ability to access HCV treatment in jurisdictions across the country. For a more detailed breakdown of our assessment criteria, check out our comprehensive rubric or complete state-by-state assessments.
Citation: Center for Health Law and Policy Innovation & National Viral Hepatitis Roundtable, Hepatitis C: State of Medicaid Access (2023), www.stateofhepc.org
A+
PA removed for most patients; no other restrictions
A
PA removed for most patients OR PA required for all patients; minimal restrictions
B
PA removed for most patients; some restrictions OR
PA required for all patients; minimal restrictions
PA required for all patients; minimal restrictions
C
PA required for all patients; some restrictions
D
PA required for all patients; many restrictions
F
PA required for all patients; harsh restrictions
Latest News
Hepatitis C: State of Medicaid Access Update Signals Tipping Point on Prior Authorization Removal is Near
Washington, D.C. (August 31, 2023) – The Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) and the National Viral Hepatitis Roundtable (NVHR) today published updates to… [Read More]
New CDC Report Reveals Only 1/3 of Hep C Diagnoses Lead to Cures, Spotlighting a Broken System in Dire Need of Coordinated National Response
FOR IMMEDIATE RELEASE WASHINGTON, D.C. (June 30, 2023) – In response to disturbing new data released by the Centers for Disease Control and Prevention (CDC), the Center for Health Law… [Read More]
CHLPI & NVHR Statement on New CDC Report Revealing Gaps in Hepatitis C Treatment in the Cherokee Nation
FOR IMMEDIATE RELEASE WASHINGTON, D.C. (June 12, 2023) – The Center for Health Law & Policy Innovation (CHLPI) of Harvard Law School and the National Viral Hepatitis Roundtable (NVHR) today… [Read More]
Take Action
SPREAD THE WORD
Access our infographics, social media toolkit and digital resources.
JOIN THE NETWORK
Join the NVHR Voices4Hep network to connect with advocates across the country pushing for policies that eliminate hepatitis C by 2030.